Igyxos is a biotech startup developing pharmaceuticals and medical technologies in the field of human fertility. The Company is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds such as small molecules and antibodies, and the acquisition of intellectual property rights to drugs and technologies that can then be brought to the development phase.